As Microsoft Refines its Life Science Strategy, Some Bioinformatics Vendors Feel the Heat

A Microsoft official said that bioinformatics vendors should not see the software giant's entry in the market as a threat, but an opportunity to focus on their "specialized functionality for the science" and "let Microsoft focus on the infrastructure."

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.

Related Stories